Scientists use machine learning and SPERRFY to decode the genetic wiring map that guides neural connections across the entire ...

Proton exchange membrane fuel cells (PEMFCs) are promising for zero-emission vehicles, but their sub-zero start-up capability remains a major hurdle. Freezing of product water inside the membrane ...

Learn how AI medical discovery is bridging the gap between lab research and bedside treatments, resulting in faster and more ...

Doctors and patients are gaining an edge in the fight against Alzheimer’s disease by catching early warning signs with new screening methods.

MicroAlgo QAS, by optimizing quantum circuit architectures, can significantly enhance the robustness of VQA in various noisy environments. By automatically searching for suitable circuit designs, QAS ...

QIMR Berghofer researchers developed STimage, an AI-powered pathology tool that detects hidden cancer biomarkers in standard ...

Ligand-based drug design combines AI and QSAR modeling to prioritize drug candidates, minimizing preclinical failures and ...

New screening tools: Hospitals are piloting tablet-based cognitive exams and AI-driven brain scan analysis to spot Alzheimer’s signs invisible to human observers. Genetic risk insight: Patients can ...

Instead of fighting disease after it strikes, AI will help us stop it before it starts. This transition towards preventative ...

A formal FDA call for repurposing nominations prioritizes areas where unmet need is high and manufacturer incentives to pursue supplemental approvals are limited. Submissions may be grounded in ...

New digital screening: Hospitals are piloting a quick, sensor-equipped cognitive exam that uses AI to detect early Alzheimer’s indicators. Genetics and risk: Genetic testing for APOE variants can help ...

Valerie Veatch’s work will make you feel all kinds of things: dismayed, icky, but also empowered with the knowledge that we are not, in fact, actually doomed to a future of AI overlords. Across her ...